MaxCyte, Inc. Common Stock
Symbol: MXCT (NASDAQ)
1.44
▲ (1.06%) 0.015
Company Description:
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.
Key Stats
- Today's Open: $1.4
- Today's High: $1.435
- Today's Low: $1.395
- Today's Volume: 96.34K
- Yesterday Close: $1.42
- Yesterday High: $1.47
- Yesterday Low: $1.395
- Yesterday Volume: 628.86K
- Last Min Volume: 308
- Last Min High: $1.435
- Last Min Low: $1.435
- Last Min VWAP: $1.435
Company Profile
- Name: MaxCyte, Inc. Common Stock
- Website: https://www.maxcyte.com
- Listed Date: 2019-12-05
- Location: ROCKVILLE, MD
- Market Status: Active
- CIK Number: 0001287098
- SIC Code: 8731
- SIC description: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
- Market Cap: $151.38M
- Round Lot: 100
- Outstanding Shares: 106.61M
- Asset Type: CS
RECENT FILINGS FOR MXCT
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-27 | 4 | View |
| 2025-08-26 | S-8 | View |
| 2025-08-13 | 4 | View |
| 2025-08-13 | 4 | View |
| 2025-08-13 | 4 | View |
| 2025-08-13 | 4 | View |
| 2025-08-13 | 4 | View |
| 2025-08-11 | 8-K | View |
| 2025-08-06 | 10-Q | View |
| 2025-08-06 | 8-K | View |
| 2025-06-25 | 8-K | View |
| 2025-06-25 | 144 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
| 2025-06-23 | 4 | View |
Latest News on MXCT